News

July 24, 2019July 24, 2019

Collaborative Project Aims to Improve Care for Advanced Ovarian Cancer Patients

News

A new collaborative project seeks to help ovarian cancer programs better understand and remove impediments to optimal care for patients with advanced epithelial disease. Called “Barriers to Quality Care in ... Read more

July 22, 2019August 26, 2019

Zejula Maintenance Therapy Extends Progression-free Survival in Advanced Ovarian Cancer Patients, Phase 3 Trial Shows

News

Maintenance treatment with Zejula (niraparib) extended the time without disease worsening in women with advanced ovarian cancer who had responded to first-line chemotherapy, according to updated results of a Phase ... Read more

July 19, 2019

Dine Out to Help Fight Ovarian and Other Cancers, SU2C and Mastercard Urge

News

Foes while in opposing dugouts, two Major League Baseball (MLB) managers are teaming up with Mastercard and Stand Up To Cancer (SU2C) to battle malignancies such as ovarian cancer. Alex Cora ... Read more

July 17, 2019

Blood Test Ably Identifies Ovarian Cancer Prior to Surgery, Clinical Trial Planned

News

A blood test successfully identified ovarian cancer from circulating cells, and may enable this cancer to be detected early and prior to surgery, results of the first phase of a ... Read more

July 15, 2019

Scientists Discover Enzyme with Key Role in Aggressive Ovarian Cancers

News

Scientists discovered a metabolic enzyme that adds methyl groups to other molecules, called nicotinamide N-methyltransferase, that plays an important role in the progression of high-grade serous carcinoma, the most deadly ... Read more

July 12, 2019July 12, 2019

MDNA55-Interferons Combo Kills Cancer Cells, Extends Lifespan of Mice with Ovarian Cancer, Study Reports

News

Combining the experimental therapy MDNA55 with anti-cancer interferons (IFNs) can effectively kill cancer cells and extend the survival of mice with metastatic ovarian cancer, new research results show. The study, ... Read more

July 10, 2019

Zejula-Keytruda Trial Results Warrant Further Investigation for Recurrent OC

News

A combination of Zejula (niraparib) and Keytruda (pembrolizumab) is well-tolerated and has promising anti-tumor activity in women with ovarian carcinoma who have failed prior platinum-based chemotherapy, results from a Phase ... Read more

July 8, 2019

Lynparza Approved in Japan as First-Line Maintenance Therapy for Advanced OC

News

Lynparza (olaparib) has been approved in Japan as a first-line maintenance treatment for women with BRCA-mutated advanced ovarian cancer that is responding, partially or completely, to their initial chemotherapy, AstraZeneca and Merck (known ... Read more

July 3, 2019

New Blood Test May Improve Ovarian Cancer Diagnosis, Study Suggests

News

A blood test that examines a panel of 11 specific proteins could help distinguish between benign tumors and malignant ovarian cancer, reducing the need for unnecessary surgeries and leading to ... Read more

July 1, 2019

Testing for Multiple Biomarkers at a Time Can Increase Early Detection of OC

News

Testing for additional biomarkers along with the well-known biomarker CA125 can improve the detection of early-stage ovarian cancer, a new study shows. The blood-based assay could significantly improve patient survival ... Read more